Childhood, adolescent and young adult cancer survivors treated with head or brain radiotherapy or cisplatin have an increased risk of hearing problems.
Because of this high risk survivors may benefit from surveillance for hearing loss.

Recommendations for surveillance for ototoxicity in survivors who were treated with platinum chemotherapy or radiotherapy to the brain or ear.
Childhood, adolescent and young adult cancer survivors treated with head or brain radiotherapy or cisplatin have an increased risk of hearing problems.
Because of this high risk survivors may benefit from surveillance for hearing loss.
Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.
Be the first to share your thoughts!

A cancer diagnosis raises questions your employer probably won't answer first: Can they dismiss you? Do you have to tell...

Discover engaging and uplifting at-home activities for cancer patients that enhance emotional well-being, reduce stress,...

Losing your hair during treatment is about identity, not vanity — and no one should feel priced out of feeling like them...